Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Jon Smith who wrote (313)	3/29/1998 4:19:00 PM
From: Wisee	Read Replies (1) \| Respond to of 1185

Jon, There is no doubt in my mind that Nortran is going a lot higher. I have been following this thread and the company for some time, and I finally decided to give my two bits worth. I would like to thank everyone for keeping this thread informative. I am not sure if everyone on this thread subscribes to Neil Maedel's Mini-Cap Analyst, but in his latest issue dated March 23/98, Maedel writes "that Nortran had visits from some distinguished scientists that evaluated the company's science and technology. These individuals included Sir David Jack (recognized as being the individual most responsible for numerous drug successes for Glaxo), Dr. Alexander Oxford (he headed the Glaxo research teams that resulted in two highly successful drugs), Dr. Allan Higgins (an ex-Pfizer employee who headed their antiarrhythmia programs), and Dr. Alan Ezrin (another drug discoverer with extensive antiarrhythmia experience)". Maedel states "that these individuals were even willing to expand energy on Nortran is in itself indicative of the merits of its technology". I think it's only a matter of time before the market realizes Nortran's potential. I think NRT will trade between $3 - $5 shortly, the same price range as Micrologix (MBI-T) and Stressgen (SSB-T). Furthermore, when Nortran signs another licensing deal with a major pharmaceutical company, we could see Nortran hit $7, similar to what Forbes Meditech (FMI-V) is trading at. Happy Days are Here, Wisee

To: Jon Smith who wrote (313)	3/30/1998 10:01:00 AM
From: Paul S.	Read Replies (4) \| Respond to of 1185

Jon, Yes, that does mean that I will buy more shares. Once a company like Nortran has all the tools in place to do the job, it is a sure sign that the stock will appreciate. Also the fact that the NRT has broke through it's all time high on daily strength, says that Nortran is on a technical breakout. I didn't realize that Maedels had wrote another article on Nortran. Did Maedels not recommend NRT at around the $.90 level. It seems that they know what they are doing and I've heard very good tings about them. Does anyone have information on how to subscribe to Maedels? Do they have a website? Nortran is trading currently at $1.92 (yeeha) I believe this is a new all time high. Paul.